Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | ADAM19 |
Upstream (Parents) |
---|
(<<) ADCY7 → ADAM19 |
(<<) ANTXR1 → ADAM19 |
(<<) ANTXR2 → ADAM19 |
(<<) AXL → ADAM19 |
(<<) CCND2 → ADAM19 |
(<<) CD274 → ADAM19 |
(<<) CD4 → ADAM19 |
(<<) COTL1 → ADAM19 |
(<<) KIAA1949 → ADAM19 |
(<<) LCP1 → ADAM19 |
(<<) LPXN → ADAM19 |
(<<) MMP12 → ADAM19 |
(<<) MMP9 → ADAM19 |
(<<) PIK3CD → ADAM19 |
(<<) PTPRE → ADAM19 |
(<<) SULF1 → ADAM19 |
(<<) TMEM39B → ADAM19 |
(<<) TNFAIP3 → ADAM19 |
Downstream (Children) |
---|
ADAM19 → ADAM8 (>>) |
ADAM19 → ARSA (>>) |
ADAM19 → CASP6 (>>) |
ADAM19 → CHST11 (>>) |
ADAM19 → EMILIN2 (>>) |
ADAM19 → FOXQ1 (>>) |
ADAM19 → FUT11 (>>) |
ADAM19 → ICAM1 (>>) |
ADAM19 → KRT75 (>>) |
ADAM19 → PTGS1 (>>) |
ADAM19 → RARB (>>) |
ADAM19 → SGK1 (>>) |
ADAM19 → TMEM158 (>>) |
ADAM19 → TRAF6 (>>) |